NCT05271370Phase 2, phase 3Terminated

An Extension Protocol for Virologically Suppressed Subjects Who Successfully Completed PRO140_CD03 Study

Study sponsor: CytoDyn, Inc.

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2022-06-20Actual
Enrollment · participants56Actual
Source updated2025-10-30Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview